- Home
- Publications
- Publication Search
- Publication Details
Title
Mitigating risk in academic preclinical drug discovery
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 14, Issue 4, Pages 279-294
Publisher
Springer Nature
Online
2015-04-01
DOI
10.1038/nrd4578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Innovation Forager
- (2014) Thomas Ungar et al. ACADEMIC MEDICINE
- Genome Editing-Enabled HTS Assays Expand Drug Target Pathways for Charcot–Marie–Tooth Disease
- (2014) James Inglese et al. ACS Chemical Biology
- Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function
- (2014) Helgi I. Ingólfsson et al. ACS Chemical Biology
- Pharmacophore Reassignment for Induction of the Immunosurveillance Cytokine TRAIL
- (2014) Nicholas T. Jacob et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A biochemical screen for GroEL/GroES inhibitors
- (2014) Steven M. Johnson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of novel pyrazolone derivatives as inhibitors of aldose reductase: An eco-friendly one-pot synthesis, experimental screening and in silico analysis
- (2014) Aparna Kadam et al. BIOORGANIC CHEMISTRY
- From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota
- (2014) Peter Dosa et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- A Unique Industrial – Academic Collaboration Towards the Next Generation of Schizophrenia Therapeutics
- (2014) Gregor Macdonald et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- To screen or not to screen: an impassioned plea for smarter chemical libraries to improve drug lead finding
- (2014) Gerry Lushington et al. Future Medicinal Chemistry
- The essential roles of chemistry in high-throughput screening triage
- (2014) Jayme L Dahlin et al. Future Medicinal Chemistry
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation
- (2014) Magid Abou-Gharbia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Undecaprenyl Diphosphate Synthase Inhibitors: Antibacterial Drug Leads
- (2014) William Sinko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Can you trust your animal study data?
- (2014) Ian S. Peers et al. NATURE REVIEWS DRUG DISCOVERY
- Rescuing US biomedical research from its systemic flaws
- (2014) B. Alberts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Proposal Regarding Reporting of In Vitro Testing Results
- (2013) M. A. Smith et al. CLINICAL CANCER RESEARCH
- Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
- (2013) D C Swinney CLINICAL PHARMACOLOGY & THERAPEUTICS
- Innovation in academic chemical screening: filling the gaps in chemical biology
- (2013) Samuel A Hasson et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- NIPTE: a multi-university partnership supporting academic drug development
- (2013) Vadim J. Gurvich et al. DRUG DISCOVERY TODAY
- Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
- (2013) Ernst Schonbrunn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Myxovirus Screen Identifies a Small-Molecule Agonist of the Host Antiviral Response
- (2013) D. Yan et al. JOURNAL OF VIROLOGY
- A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
- (2013) F. Abulwerdi et al. MOLECULAR CANCER THERAPEUTICS
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- Target validation using chemical probes
- (2013) Mark E Bunnage et al. Nature Chemical Biology
- The epigenetics pipeline
- (2013) Vivian A. DeWoskin et al. NATURE REVIEWS DRUG DISCOVERY
- Validating therapeutic targets through human genetics
- (2013) Robert M. Plenge et al. NATURE REVIEWS DRUG DISCOVERY
- The Basics of Translation
- (2013) H. Y. Zoghbi SCIENCE
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- How academic labs can approach the drug discovery process as a way to synergize with big pharma
- (2013) Arianna Loregian et al. TRENDS IN MICROBIOLOGY
- Systems biology-embedded target validation: improving efficacy in drug discovery
- (2013) Drieke Vandamme et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Drug Discovery in an Academic Setting: Playing to the Strengths
- (2013) Donna M. Huryn ACS Medicinal Chemistry Letters
- A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
- (2013) Stuart P. McElroy et al. PLOS BIOLOGY
- Challenges for Academic Drug Discovery
- (2012) William L. Jorgensen ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Putative Impact of RNA Editing on Drug Discovery
- (2012) Niels Decher et al. Chemical Biology & Drug Design
- Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
- (2012) Sachin Surade et al. CHEMISTRY & BIOLOGY
- Can we discover pharmacological promiscuity early in the drug discovery process?
- (2012) Jens-Uwe Peters et al. DRUG DISCOVERY TODAY
- Drug discovery in pharmaceutical industry: productivity challenges and trends
- (2012) Ish Khanna DRUG DISCOVERY TODAY
- Relevance of systems pharmacology in drug discovery
- (2012) Lourdes Cucurull-Sanchez et al. DRUG DISCOVERY TODAY
- Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
- (2012) Jonathan B. Baell Journal of Chemical Information and Modeling
- Development of a Rule-Based Method for the Assessment of Protein Druggability
- (2012) Emanuele Perola et al. Journal of Chemical Information and Modeling
- Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors
- (2012) Yiyu Ge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rules for Identifying Potentially Reactive or Promiscuous Compounds
- (2012) Robert F. Bruns et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Novel Family of BRAFV600E Inhibitors
- (2012) Jie Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
- (2012) R. Chugh et al. Science Translational Medicine
- Metal Impurities Cause False Positives in High-Throughput Screening Campaigns
- (2012) Johannes C. Hermann et al. ACS Medicinal Chemistry Letters
- Target Validation: Linking Target and Chemical Properties to Desired Product Profile
- (2011) Paul G. Wyatt et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- What makes a good drug target?
- (2011) Isabella Gashaw et al. DRUG DISCOVERY TODAY
- Druggability assessment of protein–protein interfaces
- (2011) Jutta Wanner et al. Future Medicinal Chemistry
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
- (2011) Chun-wa Chung et al. JOURNAL OF MEDICINAL CHEMISTRY
- KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries
- (2011) Simon Saubern et al. Molecular Informatics
- US academic drug discovery
- (2011) Stephen Frye et al. NATURE REVIEWS DRUG DISCOVERY
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Believe it or not: how much can we rely on published data on potential drug targets?
- (2011) Florian Prinz et al. NATURE REVIEWS DRUG DISCOVERY
- Structural conservation of druggable hot spots in protein-protein interfaces
- (2011) D. Kozakov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Organic synthesis toward small-molecule probes and drugs
- (2011) S. L. Schreiber PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How to Revive Breakthrough Innovation in the Pharmaceutical Industry
- (2011) B. H. Munos et al. Science Translational Medicine
- Therapeutics Development for Cystic Fibrosis: A Successful Model for a Multisystem Genetic Disease
- (2010) Melissa A. Ashlock et al. Annual Review of Medicine
- Probing the Probes: Fitness Factors For Small Molecule Tools
- (2010) Paul Workman et al. CHEMISTRY & BIOLOGY
- Apparent activity in high-throughput screening: origins of compound-dependent assay interference
- (2010) Natasha Thorne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The translatability of animal models for clinical development: biomarkers and disease models
- (2010) Alexandra Wendler et al. CURRENT OPINION IN PHARMACOLOGY
- Observations on screening-based research and some concerning trends in the literature
- (2010) Jonathan B Baell Future Medicinal Chemistry
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
- (2010) Julie A. Frearson et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
- (2010) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Driving Drug Discovery: The Fundamental Role of Academic Labs
- (2010) B. M. Silber Science Translational Medicine
- Quantifying Biological Activity in Chemical Terms: A Pharmacology Primer To Describe Drug Effect
- (2009) Terry Kenakin ACS Chemical Biology
- A survey of across-target bioactivity results of small molecules in PubChem
- (2009) L. Han et al. BIOINFORMATICS
- In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine
- (2009) Olivier Vidalin et al. CURRENT OPINION IN PHARMACOLOGY
- Towards a more robust approach to selecting and prosecuting promising targets and compounds
- (2009) Graeme Robertson Future Medicinal Chemistry
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- (2009) Frank Lovering et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4
- (2009) C. A. Lyssiotis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting druggable binding sites at the protein–protein interface
- (2008) Jonathan C. Fuller et al. DRUG DISCOVERY TODAY
- A structural biology view of target drugability
- (2008) Ursula Egner et al. Expert Opinion on Drug Discovery
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now